日本在线观看不卡,国产成人免费观看,国产gaysex男同视频chinese,欧美一级www

樹人論文網一個專業的學術咨詢網站!!!
樹人論文網
學術咨詢服務

EXPERT OPINION ON THERAPEUTIC PATENTS

來源: 樹人論文網 瀏覽次數:397次
Monthly
創刊時間:1994
所屬分區:2區
周期:Monthly
ISSN:1354-3776
影響因子:3.699
是否開源:No
年文章量:97
錄用比:一般
學科方向:藥物化學
研究方向:醫學
通訊地址:INFORMA HEALTHCARE, TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON, ENGLAND, EC2A 4LQ
官網地址:http://www.tandfonline.com/loi/ietp20#.V48csUz9cSQ
投稿地址:https://mc.manuscriptcentral.com/eotp
網友分享經驗:較慢,6-12周

EXPERT OPINION ON THERAPEUTIC PATENTS雜志中文介紹

由Informa Pharmaceutical Science出版(原名Ashley Publications)。國際標準書號:1354-3776。《關于治療專利的專家意見》(ISSN1354-3776)每月出版一期,是醫藥專利信息方面的領先專利期刊。關于治療專利的專家意見提供了一個每月的,同行評審的指導,以技術進步和藥物專利的發展。鼓勵作者對所審查研究的現狀發表專家意見,而不是簡單地審查現有數據。該期刊的每一期都包含了注釋性的專利選擇和簡短的專利評估,突出了相關專家認為具有潛在重要性的發明和創新理念。觀眾包括制藥行業的科學家、管理者和決策者,以及其他與研發密切相關的人。訂戶包括美國、歐洲和日本的大多數主要制藥公司,以及許多生物技術公司。關于治療專利的專家意見采用了系統的覆蓋方法,每個問題都集中在一個主要的治療領域。

EXPERT OPINION ON THERAPEUTIC PATENTS雜志英文介紹

Published by Informa Pharmaceutical Science (formerly Ashley Publications). ISSN: 1354-3776.Expert Opinion on Therapeutic Patents (EOTP) (ISSN 1354-3776) is published monthly and is the leading patent journal for pharmaceutical patent information. Expert Opinion on Therapeutic Patents provides a monthly, peer-reviewed guide to the technological advances and developments in pharmaceutical patents. Authors are encouraged to express their Expert Opinion of the status of the research under review, rather than to simply review the available data. Each issue of the journal contains annotated patent selections and short patent evaluations which highlight inventions and innovative ideas deemed by relevant experts to be of potential importance. The audience consists of scientists, managers and decision-makers in the pharmaceutical industry, and others closely involved in R&D. Subscribers include most of the major pharmaceutical companies in the USA, Europe and Japan, and many biotechnology companies. Expert Opinion on Therapeutic Patents adopts a systematic approach to coverage, with each issue focusing on one of the major therapeutic areas.

EXPERT OPINION ON THERAPEUTIC PATENTS影響因子